| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600070 | 注射用重组抗HER2人源化单克隆抗体组合物 | B-002 | Lyophilized | Biological Products(1) | New Drug Application | 2017-02-13 | 上海医药集团股份有限公司 | Shanghai Pharmaceuticals Holding Co Ltd | Certificate Issued | 2017-09-27 | view |